Explore more publications!

Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

Press releases published on October 27, 2025

Curia investiert 4 Mio. US-Dollar in die Optimierung der Herstellung steriler Wirkstoffe
Curia Melabur AS$4 Juta untuk Mempertingkat Pengeluaran API Steril
Curia ลงทุน 4 ล้านดอลลาร์เพื่อยกระดับการผลิต Sterile API
Curia 投資 400 萬美元增強無菌有效藥劑成分的製造
Curia משקיעה 4 מיליון דולר לשיפור ייצור API סטרילי
Curia Berinvestasi $4 Juta untuk Meningkatkan Mutu Manufaktur API Steril
Curia 投资 400 万美元改进无菌原料药(API)的制造
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
Institutional Investor and Juggernaut Capital Founder John Shulman Joins Wrap Technologies Board of Directors
Check Point Partners with Harris Blitzer Sports & Entertainment and Washington Commanders to Safeguard Teams Against Cyber Attacks
Wearable Devices Secures Exclusive Distribution Agreement in South Korea for Its Neural Input Wristbands
DIAGNOS Welcomes Dr. Pierre-Luc Charlebois to its Advisory Board
DIAGNOS accueille Dr Pierre-Luc Charlebois au sein de son comité consultatif
OMNIQ CORP to Present at the ThinkEquity Conference in New York on October 30, 2025
Advent Technologies Commissions Arxicon as Master Planner for RHyno Project
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025
EdgeMode, Inc. Files Registration Statement on Form S-1 with the SEC to Support Future Growth Financing
Three OroCommerce Customers Named Finalists in B2B eCommerce Industry Awards Americas 2025
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions